MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a large decline in short interest in August. As of August 31st, there was short interest totaling 997 shares, a decline of 94.3% from the August 15th total of 17,636 shares. Based on an average trading volume of 108,289 shares, the short-interest ratio is currently 0.0 days.
MediPharm Labs Price Performance
Shares of MEDIF traded down $0.00 during midday trading on Thursday, reaching $0.05. The stock had a trading volume of 316 shares, compared to its average volume of 78,342. The company’s fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.05. MediPharm Labs has a 1-year low of $0.04 and a 1-year high of $0.08.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
